Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Relative Risk
100%
Statin Therapy
100%
Muscle Symptoms
100%
Network Meta-analysis
100%
I(2)
90%
Number Needed to Harm
60%
Myalgia
40%
Attrition
30%
Elevated Creatine Kinase
30%
Moderate Intensity
30%
Placebo
20%
Randomized Controlled Trial
20%
Rhabdomyolysis
20%
Lipids
10%
Statins
10%
Inclusion Criteria
10%
No Significant Difference
10%
Inconsistency
10%
Creatine Kinase
10%
Sensitivity Analysis
10%
PubMed
10%
Trial Registration
10%
Cochrane Database
10%
Encoder
10%
Multicenter Randomized Controlled Trial
10%
Risk Difference
10%
Upper Normal Limit
10%
Web of Science
10%
Musculoskeletal Symptoms
10%
Treatment Intensity
10%
Therapy Intensity
10%
High-intensity Statin
10%
Random Effects Modelling
10%
Nursing and Health Professions
Number Needed to Harm
100%
Statins therapy
100%
Network Meta-Analysis
100%
Creatine Kinase
66%
Myalgia
66%
Placebo
33%
Rhabdomyolysis
33%
Medline
16%
Cochrane Library
16%
Statin (Protein)
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Musculoskeletal Disease
16%
Attributable Risk
16%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Number Needed to Harm
100%
Creatine Kinase
66%
Myalgia
66%
Randomized Controlled Trial
50%
Placebo
33%
Rhabdomyolysis
33%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Musculoskeletal Disease
16%
Biochemistry, Genetics and Molecular Biology
Statin
100%
Creatine Kinase
66%
Randomized Controlled Trial
50%
Lipid
16%
Medline
16%
Cochrane Library
16%
Web of Science
16%
Agricultural and Biological Sciences
Relative Risk
100%
Meta-Analysis
100%
Creatine Kinase
40%
Placebo
20%
Americans
10%
Spider Web
10%